Aptus Pharma Limited (BOM:544529)
472.10
-9.60 (-1.99%)
At close: Oct 27, 2026
Aptus Pharma Revenue
Aptus Pharma had revenue of 489.20M INR in the half year ending September 30, 2026, with 401.45% growth. This brings the company's total for the last twelve months to 811.18M, up 177.99% year-over-year. In the fiscal year ending March 31, 2026, Aptus Pharma had annual revenue of 465.75M with 89.65% growth. That makes Aptus Pharma the 38,046th largest company in the world by revenue and 3,384th in India.
Revenue (ttm)
811.18M
Revenue Growth
+177.99%
P/S Ratio
9.98
Revenue / Employee
8.91M
Employees
91
Market Cap
8.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 465.75M | 220.17M | 89.65% |
| Mar 31, 2025 | 245.58M | 67.01M | 37.52% |
| Mar 31, 2024 | 178.57M | 39.60M | 28.49% |
| Mar 31, 2023 | 138.97M | 33.91M | 32.27% |
| Mar 31, 2022 | 105.07M | 54.11M | 106.18% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chemkart India | 2.15B |
| Rama Vision | 1.76B |
| Novelix Pharmaceuticals | 1.47B |
| Chandra Bhagat Pharma | 1.17B |
| VijayPD Ceutical | 1.00B |
| Khemani Distributors & Marketing | 793.63M |
| Medistep Healthcare | 708.31M |
| Constronics Infra | 454.43M |